Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Global developmental delay and Intellectual disability; and very common findings: Long face. 20 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 6 | Seizure, Global developmental delay, Aggressive behavior |
STEEP1 function has not been fully characterized.
Intellectual disability, X-linked 107 has been associated with mutations in the STEEP1 gene on chromosome X.
Genetic testing for STEEP1 is available. Testing is considered supportive for diagnosis.
Phenotype severity distribution: 2 always present features, 1 very common feature, 8 common features.
No clinical trials have been registered for intellectual disability, X-linked 107.
10 publications have been identified in PubMed for intellectual disability, X-linked 107. Research spans Epidemiology / Natural History (30%), Case Report / Case Series (20%), and Basic Science / Preclinical (20%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 3 | 30% |
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 12:30 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
4 |
Narrow face, Long face, Thin upper lip vermilion |
Patient case studies
2 |
20% |
Laboratory research | 2 | 20% |
Other research | 1 | 10% |
Research summaries | 1 | 10% |
New treatment approaches | 1 | 10% |
Latunji A (2026). [PMID: 42537027](https://pubmed.ncbi.nlm.nih.gov/42537027/). *Niger J Physiol Sci*. [Review / Meta-Analysis]
Ponleitner M (2026). [PMID: 42585611](https://pubmed.ncbi.nlm.nih.gov/42585611/). *Neurology*. [Epidemiology / Natural History]
Mbachu CNP (2025). [PMID: 39295073](https://pubmed.ncbi.nlm.nih.gov/39295073/). *Clin Genet*. [Epidemiology / Natural History]
Civit A (2025). [PMID: 39523020](https://pubmed.ncbi.nlm.nih.gov/39523020/). *Clin Genet*. [Case Report / Case Series]
Singleton AL (2025). [PMID: 39641836](https://pubmed.ncbi.nlm.nih.gov/39641836/). *J Assist Reprod Genet*. [Other]
Mutlu MB (2025). [PMID: 39435674](https://pubmed.ncbi.nlm.nih.gov/39435674/). *Clin Genet*. [Basic Science / Preclinical]
Khan A (2025). [PMID: 39400946](https://pubmed.ncbi.nlm.nih.gov/39400946/). *Clin Genet*. [Basic Science / Preclinical]
Chen TY (2024). [PMID: 38684682](https://pubmed.ncbi.nlm.nih.gov/38684682/). *Cell Death Dis*. [Gene Therapy / Novel Therapeutics]
Jan TY (2024). [PMID: 38961335](https://pubmed.ncbi.nlm.nih.gov/38961335/). *J Neurodev Disord*. [Epidemiology / Natural History]
Persad-Paisley EM (2024). [PMID: 38687262](https://pubmed.ncbi.nlm.nih.gov/38687262/). *R I Med J (2013)*. [Case Report / Case Series]